Insights from 2024 WCLC


 

WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage III NSCLC

30 views
September 23, 2024
0 Comments
Login to view comments. Click here to Login